Autonomix Medical, Inc. Common Stock
AMIX · NASDAQ
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $5 | $2 | $1 | $0 |
| G&A Expenses | $7 | $5 | $1 | $14 |
| SG&A Expenses | $7 | $5 | $1 | $14 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $5 | $0 | $0 |
| Operating Expenses | $12 | $12 | $2 | $14 |
| Operating Income | -$12 | -$12 | -$2 | -$14 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $0 | -$3 | $0 | $0 |
| Pre-Tax Income | -$11 | -$15 | -$2 | -$13 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$11 | -$15 | -$2 | -$13 |
| % Margin | – | – | – | – |
| EPS | -6.46 | -21.1 | -0.11 | -0.71 |
| % Growth | 69.4% | -19,081.8% | 84.5% | – |
| EPS Diluted | -6.46 | -21.09 | -0.11 | -0.71 |
| Weighted Avg Shares Out | 2 | 1 | 19 | 19 |
| Weighted Avg Shares Out Dil | 2 | 1 | 19 | 19 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $14 |
| EBITDA | -$11 | -$15 | -$2 | $0 |
| % Margin | – | – | – | – |